Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
27%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Other(3)

Detailed Status

Completed6
unknown3
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed655%
active_not_recruiting19%
unknown327%
not_yet_recruiting19%

Recent Activity

1 active trials
Showing 5 of 11
not_yet_recruitingnot_applicable

Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With "Classic" Polycystic Ovary Syndrome (PCOS)

NCT07412028
completed

Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections

NCT03833102
active_not_recruiting

Systemic Sclerosis and Jak Inhibitors : Emphasis on Macrophages

NCT04206644
completed

Metabolomic and Proteomic Profiles of Amniotic Fluid Embolism

NCT04256083
unknownnot_applicable

Rheopheresis Mechanism in Hemodialysis Patients With PAD

NCT05373524
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07412028Not Applicable

Identification of Women With Severe Insulin Resistant Syndromes of Genetic Origin Among Patients With "Classic" Polycystic Ovary Syndrome (PCOS)

Not Yet Recruiting
NCT03833102

Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections

Completed
NCT04206644

Systemic Sclerosis and Jak Inhibitors : Emphasis on Macrophages

Active Not Recruiting
NCT04256083

Metabolomic and Proteomic Profiles of Amniotic Fluid Embolism

Completed
NCT05373524Not Applicable

Rheopheresis Mechanism in Hemodialysis Patients With PAD

Unknown
NCT04137458Not Applicable

Exploration of the Relationship Between Inflammation and Integrity of the Blood-Brain Barrier in Suicidal Behaviour

Unknown
NCT03842787

Anti-ficolin-3 Antibodies in Lupus Nephritis

Completed
NCT03352986

Substudy of CADRE: for People With Extreme Phenotype: BIOCADRE

Unknown
NCT02147210

Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1

Completed
NCT02625831

Anti-ficolin-3 Autoantibodies in Lupus Nephritis

Completed
NCT03063281

Anti-ficolin-2 Autoantibodies in Lupus Nephritis

Completed

All 11 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
11